What does NASPGHAN recommend as first line induction therapy in pediatric Crohn's disease?

What does NASPGHAN recommend as first line induction therapy in pediatric Crohn's disease?

• A. Parenteral Nutrition
• B. Gluten-Free Diet
• C. EEN - Exclusive Enteral Nutrition
• D. Corticosteroids

Answer: (C)

Exclusive Enteral Nutrition is the recommended first-line induction therapy for pediatric Crohn's disease because it directly reduces intestinal inflammation while avoiding the growth-suppressing effects of steroids. Giving a complete liquid formula for a set period, typically about 6–8 weeks, provides all necessary nutrition and allows the gut to rest and heal, often leading to clinical remission and mucosal healing. This approach supports catch-up growth and nutritional status, which are especially important in children. Parenteral nutrition is usually reserved for situations where enteral feeding isn’t possible or there is severe malnutrition that cannot be corrected enterally, so it isn’t used as the initial induction therapy. A gluten-free diet is not a standard induction treatment for Crohn's disease, as there isn’t consistent evidence that it induces remission for most pediatric patients. Corticosteroids can induce remission quickly but carry risks of growth suppression and other adverse effects in children, making them less favorable as the first-line option.

Exclusive Enteral Nutrition is the recommended first-line induction therapy for pediatric Crohn's disease because it directly reduces intestinal inflammation while avoiding the growth-suppressing effects of steroids. Giving a complete liquid formula for a set period, typically about 6–8 weeks, provides all necessary nutrition and allows the gut to rest and heal, often leading to clinical remission and mucosal healing. This approach supports catch-up growth and nutritional status, which are especially important in children.

Parenteral nutrition is usually reserved for situations where enteral feeding isn’t possible or there is severe malnutrition that cannot be corrected enterally, so it isn’t used as the initial induction therapy. A gluten-free diet is not a standard induction treatment for Crohn's disease, as there isn’t consistent evidence that it induces remission for most pediatric patients. Corticosteroids can induce remission quickly but carry risks of growth suppression and other adverse effects in children, making them less favorable as the first-line option.